Literature DB >> 24216515

High glucose concentration does not modulate the formation of arterial medial calcification in experimental uremic rats.

Tadashi Yoshida1, Maho Yamashita, Chihiro Horimai, Matsuhiko Hayashi.   

Abstract

High phosphate-induced phenotypic switching of smooth muscle cells (SMCs) into osteogenic cells is critical for the formation of arterial medial calcification in chronic kidney disease. Because vascular calcification is also prevalent in type 2 diabetes, we examined whether glucose concentration affects high phosphate-induced SMC phenotypic switching and calcification. First, the formation of arterial medial calcification was compared among 4 groups: adenine-fed uremic rats, streptozotocin-injected hyperglycemic rats, adenine-fed and streptozotocin-injected uremic/hyperglycemic rats, and control rats. Calcification was obvious in uremic and uremic/hyperglycemic rats, whereas it was undetectable in the others. Aortic calcium contents were significantly elevated in uremic and uremic/hyperglycemic rats, but they were not different between the two groups. Moreover, hyperglycemia had no effects on the reduced expression of SMC differentiation markers including smooth muscle α-actin and SM22α and on the increased expression of osteogenic markers, such as Runx2, in uremic rats. Second, cultured SMCs were incubated in the medium with various concentrations of phosphate (0.9-4.5 mmol/l) and glucose (5-50 mmol/l), and calcium deposition was measured. Although high phosphate dose-dependently increased calcium contents, they were unaffected by glucose concentration. Results suggest that glucose concentration does not directly modulate high phosphate-induced SMC phenotypic switching and arterial medial calcification.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24216515     DOI: 10.1159/000355263

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  7 in total

1.  Both high glucose and phosphate overload promote senescence-associated calcification of vascular muscle cells.

Authors:  Mingming Zhang; Tianyu Li; Zhenzhen Tu; Yuying Zhang; Xuerong Wang; Dandan Zang; Deping Xu; Yang Feng; Fan He; Mingyue Ni; Deguang Wang; Haisheng Zhou
Journal:  Int Urol Nephrol       Date:  2022-04-08       Impact factor: 2.266

Review 2.  Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities.

Authors:  Prathibha Reddy Gajjala; Maryam Sanati; Joachim Jankowski
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561

3.  Smooth Muscle-Selective Nuclear Factor-κB Inhibition Reduces Phosphate-Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease.

Authors:  Tadashi Yoshida; Maho Yamashita; Chihiro Horimai; Matsuhiko Hayashi
Journal:  J Am Heart Assoc       Date:  2017-11-16       Impact factor: 5.501

4.  Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.

Authors:  Soon-Youn Choi; Hye-Myung Ryu; Eun-Joo Oh; Ji-Young Choi; Jang-Hee Cho; Chan-Duck Kim; Yong-Lim Kim; Sun-Hee Park
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

5.  The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis.

Authors:  Anna Wärme; Henrik Hadimeri; Salmir Nasic; Bernd Stegmayr
Journal:  BMC Nephrol       Date:  2021-01-18       Impact factor: 2.388

6.  Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.

Authors:  Olivier Phan; Marc Maillard; Hartmut H Malluche; Jean-Christophe Stehle; Felix Funk; Michel Burnier
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

7.  Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury.

Authors:  Tadashi Yoshida; Maho Yamashita; Chihiro Horimai; Matsuhiko Hayashi
Journal:  J Am Heart Assoc       Date:  2014-01-27       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.